vesanoid 10 mg meke kapsule
cheplapharm arzneimittel gmbh, ziegelhof 24, greifswald, njemačka - tretinoin - kapsula, meka - 10 mg - urbroj: jedna meka kapsula sadrži 10 mg tretinoina (sve-trans-retinoična kiselina, atra)
dfv - doxivet 10
divasa-farmavic, s.a., ctra. sant hipólit, km 71, 08503 gurb-vic (barcelona), Španjolska - doksiciklin ; bromheksinklorid - koncentrirana oralna otopina - antibiotici za sistemsku upotrebu - kokoši (tovnih pilića), goveda (teladi prije početka preživanja), svinja
doxybactin 200 mg tableta za pse
le vet beheer b.v., wilgenweg 7, 3421 tv oudewater, nizozemska - doksiciklin (u obliku doksiciklinhiklata) - tableta - antibakterijski pripravci za sustavne infekcije - pasa
forticlina retard
laboratorios syva, s.a.u., av/párroco pablo díez, 49-57, 24010 león, Španjolska - oksitetraciklin - otopina za injekciju - antibakterijski vmp za sustavne infekcije - goveda, ovaca, koza i svinja
ronaxan 100
merial sas, 29, avenue tony garnier, 69007 lyon, france - doksiciklin - tableta - antibakterijski vmp za sustavne infekcije - pasa, mačaka
ronaxan 250
merial sas, 29, avenue tony garnier, 69007 lyon, france - doksiciklin - tableta - antibakterijski vmp za sustavne infekcije - pasa
enroxil 5%
krka - farma d.o.o., radnička cesta 48, 10000 zagreb, hrvatska - enrofloksacin - premiks za izradu ljekovite hrane za životinje - peradi i svinja
moxiral 400 mg/1 tableta film tableta
alkaloid d.o.o. sarajevo, isevića sokak 6, sarajevo - moksifloksacin - film tableta - 400 mg/1 tableta - 1 film tableta sadrži: 400 mg moksifloksacina (u obliku moksifloksacinhidrohlorida)
moxiral 400 mg/1 tableta film tableta
alkaloid d.o.o. sarajevo, isevića sokak 6, sarajevo - moksifloksacin - film tableta - 400 mg/1 tableta - 1 film tableta sadrži: 400 mg moksifloksacina (u obliku moksifloksacinhidrohlorida)
venclyxto
abbvie deutschland gmbh co. kg - venetoclax - leukemija, limfocitna, kronična, b-stanica - antineoplastična sredstva - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.